MDC Translational Science and Clinical Research Grants Competition Opens for 2024-25
Muscular Dystrophy Canada’s annual Neuromuscular Research Grant Program is now open for 2024-25!
The annual Neuromuscular Research Grant Program invests in projects related to the diagnosis, treatment, or clinical care of neuromuscular disorders. These grants are intended to: fill gaps in the existing funding landscape; enable researchers to build new and innovative research; support proof-of-concept, feasibility and pilot studies in preparation for larger-scale, longer-term grants from external sources. MDC grants also facilitate partnerships between researchers and patients.
Two streams are available: Translational Science Grants and Clinical Research Grants
- Application Open: September 3, 2024
- Application Deadline: November 18, 2024 at 11:59 pm (ET)
- Notice of Decision: March 3, 2025
- Funding Start Date: April 1, 2025
MDC welcome research grants focused on one or multiple neuromuscular disorders (NMD). In this cycle, we especially encourage proposals focusing on Friedreich ataxia, Charcot-Marie-Tooth disease / hereditary motor and sensory neuropathies (HMSN), myotonic dystrophy, limb-girdle muscular dystrophy and collagen VI-related dystrophy.
Visit the MDC Translational Science and Clinical Research Grants webpage to learn more, or view the funding application guidelines here. For further inquiries, please contact Dr. Homira Osman, VP of Research and Public Policy, Muscular Dystrophy Canada at <>.
Read next...
Applications Open for New NMD4C Collaborative Research Training Awards!
The NMD4C is excited to announce a new program for neuromuscular research trainees that will support collaboration opportunities between Canadian research labs.
NMD4C Members Receive Dr David Green Awards from Muscular Dystrophy Canada
We are excited to share that several NMD4C investigators and members have been honored with a Dr David Green Award from Muscular Dystrophy Canada!
Lower Extremity Muscle Strengthening Program in Myotonic Dystrophy Type 1 from Groupe de recherche interdisciplinaire sur les maladies neuromusculaires
The Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN) recently created a video aimed at health professionals that provides an in-depth explanation of the Myotonic dystrophy (DM1) training parameters used in their studies.
Fifth Annual Clinical Fellowship Competition from NMD4C and MDC Opens May 1st
The NMD4C and MDC clinical neuromuscular fellowship competition is accepting applications for the 2026 competition until June 12, 2025.
